E-LIB Suche - Ergebnisse für: Shen, Tiansheng

1

Performance Analysis of Leica Biosystems Monoclonal Antibod..:

Shilo, Konstantin ; Shen, Tiansheng ; Hammond, Scott...
Applied Immunohistochemistry & Molecular Morphology. , 2024

Link: https://doi.org/10.1097/..

2

TRPS1, GATA3, and SOX10 expression in triple-negative breas..:

Yoon, Esther C. ; Wang, Gang ; Parkinson, Bryce...
Human Pathology. 125 (2022) - p. 97-107 , 2022

Link: https://doi.org/10.1016/..

3

An Indoor positioning method based on Improved Elman neural..:

, In: 2022 7th International Conference on Communication, Image and Signal Processing (CCISP),

Shen, Tiansheng ; Chen, Wenying ; Zhu, Binbin... - p. 376-381 , 2022

Link: https://doi.org/10.1109/..

4

Unusual staining of immunohistochemical markers PAX8 and CD..:

Shen, Tiansheng ; Zhao, Jun ; Zhao, Min...
Human Pathology. 125 (2022) - p. 35-47 , 2022

Link: https://doi.org/10.1016/..

5

M2 tumor-associated macrophages play important role in pred..:

Arole, Vidya ; Nitta, Hiroaki ; Wei, Lai...
Breast Cancer Research and Treatment. 188 (2021) 1 - p. 37-42 , 2021

Link: https://doi.org/10.1007/..

6

Prognostic value of androgen receptor expression and molecu..:

Shen, Tiansheng ; Wei, Lai ; Li, Xiaoxian..
Human Pathology. 116 (2021) - p. 73-81 , 2021

Link: https://doi.org/10.1016/..

7

HER2 intratumoral heterogeneity is independently associated..:

Shen, Tiansheng ; Nitta, Hiroaki ; Wei, Lai..
Breast Cancer Research and Treatment. 181 (2020) 3 - p. 519-527 , 2020

Link: https://doi.org/10.1007/..

8

The PD-1/PD-L1 Axis in HER2+ Ductal Carcinoma In Situ (DCIS..:

Ubago, Julianne M ; Blanco Jr, Luis Z ; Shen, Tiansheng.
American Journal of Clinical Pathology. 152 (2019) 2 - p. 169-176 , 2019

Link: https://doi.org/10.1093/..

9

Corrigendum to "Diagnostic utility of IDH1/2 mutations to d..:

Chen, Shaoxiong ; Fritchie, Karen ; Wei, Shi...
Human Pathology. 69 (2017) - p. 143 , 2017

Link: https://doi.org/10.1016/..

10

The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the ..:

Wang, Kai ; Shen, Tiansheng ; Siegal, Gene P..
Human Pathology. 69 (2017) - p. 110-117 , 2017

Link: https://doi.org/10.1016/..

11

Diagnostic utility of IDH1/2 mutations to distinguish dedif..:

Chen, Shaoxiong ; Fritchie, Karen ; Wei, Shi...
Human Pathology. 65 (2017) - p. 239-246 , 2017

Link: https://doi.org/10.1016/..

12

Prognostic outcomes in advanced breast cancer: the metastas..:

Shen, Tiansheng ; Gao, Cheng ; Zhang, Kui..
Human Pathology. 70 (2017) - p. 70-76 , 2017

Link: https://doi.org/10.1016/..

13

Prognostic Value of E-Cadherin and β-Catenin in Triple-Nega..:

Shen, Tiansheng ; Zhang, Kui ; Siegal, Gene P..
American Journal of Clinical Pathology. 146 (2016) 5 - p. 603-610 , 2016

Link: https://doi.org/10.1093/..

14

Prognostic factors in advanced breast cancer: Race and rece..:

Ren, Zhiyong ; Li, Yufeng ; Shen, Tiansheng...
Pathology - Research and Practice. 212 (2016) 1 - p. 24-30 , 2016

Link: https://doi.org/10.1016/..

15

ERBB2 mutation is associated with a worse prognosis in pati..:

Ping, Zheng ; Siegal, Gene P. ; Harada, Shuko...
Oncotarget. 7 (2016) 49 - p. 80655-80663 , 2016

Link: https://doi.org/10.18632..